Focal therapy in localised prostate cancer: Real-world urological perspective explored in a cross-sectional European survey

Autor: Marra, G, Ploussard, G, Ost, P, De Visschere, PJL, Briganti, A, Gandaglia, G, Tilki, D, Surcel, CI, Tsaur, I, Van Den Bergh, RCN, Kretschmer, A, Borgmann, H, Gontero, P, Ahmed, HU, Valerio, M, EAU-YAU Prostate Cancer Working Party

Publikováno v: 529.e22
529.e11

Introduction: The urological community's opinion over focal therapy (FT) for prostate cancer (PCa) has never been assessed. Our aim was to investigate the current opinion on FT in the European urological community. Methods: A 25 -item questionnaire w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b61b7d36a990e88e135d3446801d91e3
https://doi.org/10.1016/j.urolonc.2018.08.013

How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.

Autor: Gandaglia G; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy., van den Bergh RCN; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Tilki D; Martini-Klinik Prostate Cancer Center, University-Hospital Hamburg-Eppendorf, Hamburg, Germany.; Department of Urology, University-Hospital Hamburg-Eppendorf, Hamburg, Germany., Fossati N; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy., Ost P; Department of Radiotherapy, Ghent University Hospital, Ghent, Belgium., Surcel CI; Centre of Urological Surgery, Dialysis and Renal Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Sooriakumaran P; Department of Uro-oncology, University College London Hospital, London, UK., Tsaur I; Department of Urology, University Medicine Mainz, Mainz, Germany., Valerio M; Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Kretschmer A; Urologische Klinik und Poliklinik, Campus Großhadern, Ludwig-Maximilians-Universität, Munich, Germany., Zaffuto E; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy., Salomon L; Department of Urology, Henri Mondor Hospital, Assistance-Publique Hopitaux de Paris, Creteil, France., Montorsi F; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Graefen M; Martini-Klinik Prostate Cancer Center, University-Hospital Hamburg-Eppendorf, Hamburg, Germany., van der Poel H; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de la Taille A; Department of Urology, Henri Mondor Hospital, Assistance-Publique Hopitaux de Paris, Creteil, France., Briganti A; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Ploussard G; Department of Urology, Henri Mondor Hospital, Assistance-Publique Hopitaux de Paris, Creteil, France.; Department of Urology, Saint Jean Languedoc Hospital, Toulouse, France.

Publikováno v: BJU international [BJU Int] 2018 Nov; Vol. 122 (5), pp. 823-830. Date of Electronic Publication: 2018 Jun 03.

Role of multiparametric magnetic resonance imaging in early detection of prostate cancer.

Autor: De Visschere PJ; Department of Radiology, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. pieter.devisschere@uzgent.be., Briganti A; Department of Urology, Urological Research Institute, Vita-Salute University San Raffaele, Milan, Italy., Fütterer JJ; Department of Radiology and Nuclear Medicine, Radboud UMC, Nijmegen, The Netherlands., Ghadjar P; Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany., Isbarn H; Department of Urology, Regio Clinic Wedel, Wedel, Germany.; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Massard C; Department of Oncology, Institut Gustave Roussy, University of Paris Sud, Villejuif, France., Ost P; Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium., Sooriakumaran P; Surgical Intervention Trials Unit, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.; Department of Molecular Medicine & Surgery, Karolinska Institutet, Stockholm, Sweden., Surcel CI; Centre of Urological Surgery, Dialysis and Renal Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Valerio M; Department of Urology, CHUV, Lausanne, Switzerland., van den Bergh RC; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands., Ploussard G; Urology Department, Saint Jean Languedoc Hospital, Toulouse, France.; Research Unit INSERM U955, Paris Est University, Team 7, Paris, France., Giannarini G; Urology Unit, Academic Medical Centre Hospital «Santa Maria della Misericordia», Udine, Italy., Villeirs GM; Department of Radiology, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium.

Publikováno v: Insights into imaging [Insights Imaging] 2016 Apr; Vol. 7 (2), pp. 205-14. Date of Electronic Publication: 2016 Feb 04.

Prognostic effect of neuroendocrine differentiation in prostate cancer: A critical review.

Autor: Surcel CI; Centre of Urological Surgery, Dialysis and Renal Transplantation, Fundeni Clinical Institute, Bucharest, Romania., van Oort IM; Department of Urology, Radboud University Medical Centre, Nijmegen, The Netherlands., Sooriakumaran P; Surgical Intervention Trials Unit, Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Briganti A; Division of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy., De Visschere PJ; Department of Radiology, Ghent University Hospital, Ghent, Belgium., Fütterer JJ; Department of Radiology, Radboud University Medical Centre, Nijmegen, The Netherlands., Ghadjar P; Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany., Isbarn H; Department of Urology, Regio Clinic Wedel, Wedel, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Ost P; Department of Radiation Oncology and Experimental Cancer Research, Ghent University Hospital, Ghent, Belgium., van den Bergh RC; Department of Urology, University Medical Centre Utrecht, Utrecht, The Netherlands., Yossepowitch O; Department of Urology, Rabin Medical Center-Beilinson, Petach-Tikva, Israel; Sackler Faculty of Medicine, University of Tel Aviv, Tel Aviv, Israel., Giannarini G; Department of Experimental and Clinical Medical Sciences, Urology Unit, University of Udine, Udine, Italy., Ploussard G; Department of Urology, CHU Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université Paris 7 Diderot, Paris, France. Electronic address: g.ploussard@gmail.com.

Publikováno v: Urologic oncology [Urol Oncol] 2015 Jun; Vol. 33 (6), pp. 265.e1-7. Date of Electronic Publication: 2014 Sep 17.

Preferences in the management of high-risk prostate cancer among urologists in Europe: results of a web-based survey.

Autor: Surcel CI; Centre of Uronephrology and Renal Transplantation, Fundeni Clinical Institute, 'Carol Davila' University of Medicine and Pharmacy, Bucharest, Romania., Sooriakumaran P, Briganti A, De Visschere PJ, Fütterer JJ, Ghadjar P, Isbarn H, Ost P, Ploussard G, van den Bergh RC, van Oort IM, Yossepowitch O, Sedelaar JP, Giannarini G

Publikováno v: BJU international [BJU Int] 2015 Apr; Vol. 115 (4), pp. 571-9. Date of Electronic Publication: 2014 Aug 11.